[¿Óóµ¥Àϸ®] ÇѸ²´ëÇб³¼º½Éº´¿ø(º´¿øÀå Á¤±â¼®) À¯¹æ³»ºÐºñ¾Ï¼¾ÅÍ(¼¾ÅÍÀå ±èÀ̼ö)´Â 10¿ù 18ÀÏ(ÀÏ) ¿ÀÀü 8½Ã 20ºÐºÎÅÍ ¿ÀÈÄ 4½Ã 50ºÐ±îÁö º»°ü 4Ãþ ÇѸ¶À½È¦¿¡¼ ¡®Á¦8ȸ 2015 ÇѸ²´ëÇб³¼º½Éº´¿ø À¯¹æ¾Ï¿¬¼ö°Á¡¯¸¦ °³ÃÖÇÑ´Ù.
À̹ø ¿¬¼ö°Á´ À¯¹æ³»ºÐºñ¾Ï¼¾ÅÍ ±èÀ̼ö ¼¾ÅÍÀåÀÇ °³È¸»ç·Î ½ÃÀÛÇÑ´Ù. ¼¼¼Ç 1. Breast Imaging and Pathology(À¯¹æ¿µ»ó°ú º´¸®) ÁÖÁ¦·Î °Ç±¹ÀÇ´ë ¾çÁ¤Çö ±³¼ö°¡ ÁÂÀåÀ» ¸Ã¾Æ ¡ãÇѸ²ÀÇ´ë Á¤±Õ¼ø ±³¼ö°¡ Mastering the art of mammographic screening(À¯¹æÃÔ¿µ¼ú ÀÌÇØÀÇ ¿Ï°áÆÇ), ¡ã¼º±Õ°üÀÇ´ë ÃÖÁö¼ö ±³¼ö°¡ Screening sono-detected lesion: What do you do next? (À¯¹æÃÊÀ½ÆÄ¿¡¼ ¹ß°ßµÈ º´º¯¿¡ ´ëÇÑ Ãß°¡°Ë»ç), ¡ãÇѸ²ÀÇ´ë ¹Î¼ö±â ±³¼ö°¡ Lobular neoplasia : Differential Diagnosis and Therapeutic Implications(ÇöÀçÀÇ ÇÖÀ̽´ÀÎ ¼Ò¿±½Å»ý¹°ÀÇ °¨º°°ú Ä¡·á¿¡ ´ëÇÑ ÃÖ½ÅÁö°ß), ¡ã°í·ÁÀÇ´ë ¿ì»ó¿í ±³¼ö°¡ Clinician's guide to pathologic findings in breast disease(º´¸®Á¶Á÷°Ë»ç¿¡ µû¸¥ À¯¹æ¿Ü°úÀÇ»çÀÇ Ä¡·á °¡À̵å¶óÀÎ)¿¡ ´ëÇØ °ÀÇÇϰí ÅäÀÇÇÑ´Ù.
¼¼¼Ç 2. Luncheon Symposium Çü½ÄÀ¸·Î Â÷ÀÇ´ë ¹ÚÇØ¸° ±³¼ö°¡ ÁÂÀåÀ» ¸Ã¾Æ ¡ã¿¬¼¼ÀÇ´ë ¼ÕÁÖÇõ ±³¼ö°¡ New Strategies in systemic treatment: Immunotherapy(ÇöÀç Ç×¾ÏÄ¡·á¿¡¼ ÇÖÀ̽´ÀÎ ¸é¿ªÄ¡·á¿¡ ´ëÇÑ »õ·Ó°Ô ¹ßÀüµÈ ÃÖ½ÅÁö°ß)¿¡ ´ëÇØ °ÀÇÇϰí Åä·ÐÇÑ´Ù.
¼¼¼Ç 3. Practical issues in Breast Clinics(À¯¹æÅ¬¸®´Ð ȯÀÚÀÇ ½ÇÁúÀû Ä¡·á°æÇè) ÁÖÁ¦·Î Àü³²ÀÇ´ë À±Á¤ÇÑ ±³¼ö°¡ ÁÂÀåÀ» ¸Ã¾Æ ¡ãÃæ¹«º´¿ø ·ùÁø¿ì °úÀåÀÌ Management of Gynecomastia(Surgery, Liposuction, Mommotome) in local clinics(³²¼ºÀÇ ¸» ¸øÇÒ °í¹Î ¿©¼ºÇüÀ¯¹æÀÇ Ä¡·á¿¡ ´ëÇÑ 20¿©³âÀÇ °æÇè), ¡ã¹ÚÈñºØ¿Ü°ú ¹ÚÈñºØ ¿øÀåÀÌ Vacuum-assisted breast biopsy : Useful tips from experienced physician(¿ì¸®³ª¶ó ¸¾¸ðÅè ½Ã¼úÀ» Á¦ÀÏ ¸¹ÀÌ ½ÃÇàÇÑ Àϼ± ÇöÀå¿¡¼ÀÇ À¯¹æ¿Ü°úÀÇ»çÀÇ ´Ù¾çÇÑ Ä¡·á°æÇè), ¡ã¹ÌÁî¸Þµðº´¿ø ±èµµÀÏ °úÀåÀÌ Management of breast pain and inflammatory disease(¿©¼ºÀü¹®º´¿ø¿¡¼ 20¿©³âÀÇ À¯¹æ¿°Áõ Áúȯ°ú À¯¹æÅë¿¡ ´ëÇÑ Ä¡·á°æÇè)¿¡ ´ëÇØ °ÀÇÇϰí Åä·ÐÇÑ´Ù.
¼¼¼Ç 4. Current Issues in Breast Cancer(À¯¹æ¾ÏÀÇ Ä¡·á¿¡ ´ëÇÑ ÃÖ½ÅÁö°ß) ÁÖÁ¦·Î ¿ï»êÀÇ´ë ¼Õº´È£ ±³¼ö°¡ ÁÂÀåÀ» ¸Ã¾Æ ¡ãÀüºÏÀÇ´ë À±ÇöÁ¶ ±³¼ö°¡ How to overcome resistance to anti-HER2 agents(Ç¥ÇǼºÀåÀÎÀÚ¼ö¿ë±â¿¡ ´ëÇÑ Ç×Ç¥ÀûÄ¡·áÁ¦¿¡ ³»¼ºÀÌ »ý±ä °æ¿ì ¾î¶»°Ô ±Øº¹ÇÒ °ÍÀΰ¡?), ¡ã¼º±Õ°üÀÇ´ë ¹Ú¿ø ±³¼ö°¡ Tailoring or omitting radiotherapy(¹æ»ç¼±Ä¡·á¿¡ ´ëÇÑ ¸ÂÃãÄ¡·á¿Í ¾î¶² °æ¿ì¿¡ »ý·«ÇÒ ¼ö ÀÖ´ÂÁö¿¡ ´ëÇÑ ÃÖ½ÅÁö°ß), ¡ã°¡Å縯ÀÇ´ë ¹Ú¿ìÂù ±³¼ö°¡ Advances in endocrine therapy & endocrine resistance(À¯¹æ¾Ï Ä¡·áÀÇ ÇϳªÀÎ ³»ºÐºñÄ¡·áÀÇ ¹ßÀü °á°ú¿Í ³»ºÐºñÄ¡·á¿¡ ´ëÇÑ ÀúÇ×ÀÌ »ý±ä °æ¿ì ¾î¶»°Ô ±Øº¹ÇÒ ¼ö ÀÖ´ÂÁö¿¡ ´ëÇÑ ÃÖ½ÅÁö°ß), ¡ã¿¬¼¼ÀÇ´ë ±è½ÂÀÏ ±³¼ö°¡ Circulating tumor cells and metastatic breast cancer(Ç÷¾×¼ÓÀ» ¼øÈ¯ÇÏ´Â ¾Ï¼¼Æ÷¿Í ÀüÀ̼º À¯¹æ¾ÏÀÇ °ü°è¿¡ ´ëÇÑ ÃÖ½ÅÁö°ß)¿¡ ´ëÇØ °ÀǸ¦ ³¡À¸·Î À¯¹æ³»ºÐºñ¾Ï¼¾ÅÍÀå ±èÀ̼ö ±³¼öÀÇ Æóȸ»ç·Î ¸¶¹«¸®ÇÑ´Ù.
ÇѸ²´ëÇб³¼º½Éº´¿ø À¯¹æ³»ºÐºñ¾Ï¼¾ÅÍÀå ±èÀ̼ö ±³¼ö´Â ¡°À̹ø ¿¬¼ö°Á´ À¯¹æ¾ÏÄ¡·áÀÇ °¢ ºÐ¾ßº° Àü¹®Àǰ¡ ÇÑ ÀÚ¸®¿¡ ¸ð¿© ȯÀÚ¸¦ Á¤È®ÇÏ°Ô Áø´ÜÇϰí ÃÖÀûÀÇ Ä¡·á°èȹÀ» µµÃâÇÒ ¼ö ÀÖµµ·Ï ´Ù¾çÇÑ °ÀǸ¦ ¸¶·ÃÇÏ¿© À¯¹æ¾ÏÀÇ ÀÌÇØ¿Í Ä¡·á¿¡ ÇÑ ´Ü°è ¹ßÀüÇÑ ÆÐ·¯´ÙÀÓÀ» ¼±º¸ÀÏ °Í¡±À̶ó¸ç ¡°Áö¿ª»çȸ ÀÇ·á¹ßÀü¿¡ µµ¿òÀÌ µÇ°í Áø·áÇöÀå¿¡¼ °æÇèÇÑ Áõ·Ê¿¡ ´ëÇÏ¿© ¼·Î ÅäÀÇÇÏ´Â À¯ÀÍÇÑ Á¤º¸ ±³·ùÀÇ ÀåÀÌ µÉ ¼ö ÀÖÀ» °Í¡±À̶ó°í Âü¿©¸¦ µ¶·ÁÇß´Ù.
ÇÑÆí, ÇѸ²´ëÇб³¼º½Éº´¿ø À¯¹æ¾Ï¿¬¼ö°Á´ °æ±â.ÀÎõ Áö¿ª À¯ÀÏÇÑ À¯¹æ¾Ï¿¬¼ö°Á·μ º¯ÈÇÏ´Â ÀÇ·á ȯ°æ¿¡¼ ¸Å³â ¾ËÂ÷°í À¯ÀÍÇÑ °ÀÇ ³»¿ëÀ» ÁغñÇØ À¯¹æÄ¡·á Àü¹®°¡µéÀÇ ¹ßÇ¥¿Í Åä·ÐÀÇ ÀåÀ¸·Î ÀÚ¸®¸Å±è Çϰí ÀÖ´Ù.
À̹ø ¿¬¼ö°Á´ ´ëÇÑÀÇ»çÇùȸ ¿¬¼öÆòÁ¡ 6Á¡À» ºÎ¿©Çϸç, °Á µî·Ï ¹× ¹®ÀÇ´Â ÇѸ²´ëÇб³¼º½Éº´¿ø À¯¹æ³»ºÐºñ¾Ï¼¾ÅÍ(ÀüÈ 031-380-5930, 5931, 5932)·Î ÇÏ¸é µÈ´Ù. |